Published

Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: Neuroscience
Date: 2025-08-01
Source: OpenAlex
DOI: 10.1016/j.neuroscience.2025.05.064
PubMed: Unavailable

Authors

Mickaël Naassïla

Watch author

Derived topics and classifications

psilocybin Addiction Receptor Pharmacology Animal Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine2025-08-01

Related papers

Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2026-01-01 Psychedelic Drug Therapy for Mental Disorders?Open Journal of Medical Psychology · 2023-01-01 A-118 Psychedelic Interventions for Neuropsychological ConditionsArchives of Clinical Neuropsychology · 2022-08-16 Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of AlcoholismJournal of Humanistic Psychology · 2016-10-16 B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult PopulationsArchives of Clinical Neuropsychology · 2024-09-12 Expectancies for Subjective and Antidepressant Effects in Psilocybin UsersJournal of Humanistic Psychology · 2023-09-22 Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?Journal of Humanistic Psychology · 2022-08-18 Developing Guidelines and Competencies for the Training of Psychedelic TherapistsJournal of Humanistic Psychology · 2017-06-29